Research status and advances in immunotherapy for chronic myeloid leukemia

Chronic myeloid leukemia (CML) is a malignant hematologic disorder caused by abnormal proliferation of hematopoietic stem cells. In recent years, while the application of tyrosine kinase inhibitors (TKIs) has significantly improved the prognosis of CML patients through in-depth exploration of pathog...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	WANG Mengmeng, MA Jingyun, XIONG Boyu, DAI Zhuowen, PAN Yueyue, WANG Qiong
פורמט:	Artigo
שפה:	Chinês
יצא לאור:	Institute of Blood Transfusion of Chinese Academy of Medical Sciences 2025-05-01
סדרה:	Zhongguo shuxue zazhi
נושאים:	chronic myeloid leukemia immunotherapy t cells nk cells telomeres
גישה מקוונת:	https://www.cjbt.cn/thesisDetails#10.13303/j.cjbt.issn.1004-549x.2025.05.022&lang=en
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!